PER-011-03已完成未知
A RANDOMIZED, DOUBLE-BLIND, MULTICENTRIC STUDY TO EVALUATE THE TOLERABILITY AND EFFECTIVENESS OF 90 MG ETORICOXIB ONCE A DAY COMPARED WITH 75 MG SODIUM DICLOFENACO TWICE A DAY IN PATIENTS WITH RHEUMATOID ARTHRITIS.
MERCK & CO.INC.,0 个研究点目标入组 0 人开始时间: 2003年2月25日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •a. The patient is a male or a woman at least 50 years old.
- •b. The patient has a clinical diagnosis of rheumatoid arthritis (must have met at least 4 of 7 revised criteria of the 1987 ARA at some time in the past) and the investigator will require a chronic therapy with NSAIDs or a selective COX-2 inhibitor .
- •c. The patient understands the study procedures and agrees to participate in the
- •study, through written informed consent.
排除标准
- •a. The patient has a functional Class IV diagnosis according to the American
- •College of Rheumatology (ACR).
- •b. The patient has a concurrent medical or rheumatic disease that could
- •confuse or interfere with the evaluation of effectiveness.
研究者
相似试验
已完成
不适用
A RANDOMIZED, DOUBLE-BLIND, MULTICENTRIC STUDY TO EVALUATE THE TOLERABILITY AND EFFECTIVENESS OF ETORICOXIB 90 MG PER DAY, VS. SODIC DICLOFENACO 50 MG THREE TIMES A DAY IN PATIENTS WITH OSTEOARTHRITIS.-M15M15PER-054-02MERCK SHARP & DOHME PERU S.R.L.,
已完成
不适用
A RANDOMIZED, DOUBLE-BLIND, MULTICENTRIC STUDY OF ZOLEDRONIC ACID (4 MG AND 8 MG) ADMINISTERED INTRAVENOUSLY TO PATIENTS WITH RECIDIVAL OR REFRACTORY HYPERCALCEMIA, INDUCED BY NEOPLASIA.-E835 Disorders of calcium metabolismDisorders of calcium metabolismE835PER-062-02OVARTIS BIOSCIENSES PERU S.A.,
已完成
不适用
A DOUBLE-BLIND, RANDOMIZED, MULTI-CENTRAL STUDY OF 3 PERIODS, CROSSED TO EVALUATE THE EFFECTS OF A SINGLE DOSE OF MONTELUKAST COMPARED TO THE PLACEBO AND SALMETEROL IN BRONCHOCONSTRICTION INDUCED BY EXERCISE-J45J45PER-059-05MERCK & CO.INC.,
未知
不适用
A RANDOMIZED, DOUBLE-BLIND, MULTI-CENTER STUDY TO EVALUATE THE EFFICACY AND SAFETY OF INTRAVENOUS TO ORAL SOLITHROMYCIN (CEM-101) COMPARED TO INTRAVENOUS TO ORAL MOXIFLOXACIN IN THE TREATMENT OF ADULT PATIENTS WITH COMMUNITY-ACQUIRED BACTERIAL PNEUMONIA.-J159 Bacterial pneumonia, unspecifiedBacterial pneumonia, unspecifiedJ159PER-028-14Cempra Pharmaceuticals, Inc.,9
已完成
不适用
A MULTI-CENTER, RANDOMIZED, DOUBLE-BLIND STUDY TO COMPARE THE EFFICACY AND SAFETYOF CADAZOLID VERSUS VANCOMYCIN IN SUBJECTS WITH CLOSTRIDIUM DIFFICILE-ASSOCIATEDDIARRHEA (CDAD)-A047 Enterocolitis due to Clostridium difficileEnterocolitis due to Clostridium difficileA047PER-087-13Actelion Pharmaceuticals Ltd,1